Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
002351 Edifier Technology
- 14.52
- -0.06-0.41%
Not Open Apr 1 15:00 CST
12.91BMarket Cap28.75P/E (TTM)
14.71High14.45Low75.21KlotVolume14.62Open14.58Pre Close109.52MTurnover1.44%Turnover Ratio28.75P/E (Static)889.11MShares20.4152wk High4.63P/B7.57BFloat Cap9.0752wk Low16.04Limit Up521.04MShs Float23.39Historical High13.12Limit Down1.78%Amplitude0.76Historical Low0.20Dividend TTM14.56Avg Price46.98KlotAsk1.38%Div YieldTTM100Lot Size25.83KlotBid
Edifier Technology Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 9.27%2.94B | 15.22%2.15B | 16.05%1.38B | 25.08%679.06M | 21.64%2.69B | 21.56%1.86B | 19.42%1.19B | 13.50%542.9M | -3.88%2.21B | -8.07%1.53B |
| Operating revenue | 9.27%2.94B | 15.22%2.15B | 16.05%1.38B | 25.08%679.06M | 21.64%2.69B | 21.56%1.86B | 19.42%1.19B | 13.50%542.9M | -3.88%2.21B | -8.07%1.53B |
| Other operating revenue | 9.72%62.32M | ---- | -12.26%22.65M | ---- | 27.31%56.8M | ---- | 32.73%25.81M | ---- | -2.21%44.62M | ---- |
| Total operating cost | 8.17%2.4B | 14.23%1.73B | 14.11%1.11B | 21.78%540.18M | 14.88%2.22B | 12.85%1.52B | 11.19%972.26M | 4.73%443.57M | -3.24%1.93B | -5.48%1.34B |
| Operating cost | 4.00%1.76B | 9.46%1.28B | 6.96%810.72M | 14.47%406.91M | 13.78%1.69B | 11.96%1.17B | 11.29%757.96M | 5.62%355.47M | -4.71%1.48B | -7.53%1.05B |
| Operating tax surcharges | 11.10%23.2M | 12.35%18.35M | 4.91%11.9M | 19.33%6.73M | 8.76%20.88M | 14.80%16.33M | 31.60%11.34M | 11.57%5.64M | 10.58%19.2M | 25.20%14.23M |
| Operating expense | 31.52%380.42M | 38.55%260.87M | 55.30%178.31M | 76.01%78.7M | 40.80%289.25M | 44.57%188.29M | 39.00%114.81M | 21.18%44.71M | 0.78%205.44M | -0.59%130.24M |
| Administration expense | -1.73%86.06M | 8.72%60.79M | 5.16%38.87M | 18.53%19.03M | 5.65%87.57M | -3.65%55.91M | -9.43%36.96M | -18.26%16.06M | 2.85%82.89M | 10.24%58.03M |
| Financial expense | 19.45%-27.03M | -13.89%-23.63M | -29.64%-18.16M | -90.34%-11.36M | -2,137.43%-33.55M | -563.44%-20.75M | -547.29%-14.01M | -1,211.55%-5.97M | -31.64%1.65M | 233.30%4.48M |
| -Interest expense (Financial expense) | -31.65%417.06K | -35.82%325.49K | -35.53%220.6K | -42.21%103.07K | 38.29%610.19K | 83.40%507.18K | 95.14%342.15K | 112.24%178.33K | 3.95%441.25K | -18.80%276.54K |
| -Interest Income (Financial expense) | 22.60%-27.43M | 4.72%-22.69M | -10.38%-18.32M | -35.98%-11.31M | -345.26%-35.44M | -547.36%-23.81M | -987.54%-16.6M | -2,652.62%-8.32M | -726.24%-7.96M | -448.31%-3.68M |
| Research and development | 9.16%183.62M | 27.23%131.81M | 34.72%87.83M | 45.18%40.16M | 20.13%168.2M | 16.31%103.6M | 12.01%65.19M | 11.29%27.66M | 2.75%140.02M | -3.44%89.07M |
| Credit Impairment Loss | -701.50%-2.79M | -32.10%-3.95M | -3.36%-3.6M | 82.62%-539.33K | -68.07%464.46K | -76.50%-2.99M | -50.93%-3.48M | -566.70%-3.1M | 227.17%1.45M | 20.34%-1.69M |
| Asset Impairment Loss | 41.07%-10.22M | -32.79%-7.16M | -32.79%-7.16M | --0 | -25.52%-17.34M | -2.22%-5.39M | -2.22%-5.39M | --0 | 30.27%-13.81M | 51.84%-5.27M |
| Other net revenue | -32.36%24.79M | 1,073.92%16.72M | 701.78%7.02M | 1,140.29%6.05M | 65.42%36.66M | -93.71%1.42M | -107.53%-1.17M | -103.77%-581.67K | -71.92%22.16M | -68.63%22.65M |
| Fair value change income | 490.25%16.31M | 408.28%10.26M | 448.18%6M | 273.81%1.29M | -83.78%2.76M | -86.10%2.02M | -89.31%1.09M | -93.08%346.21K | 54.73%17.03M | 153.19%14.52M |
| Invest income | -78.40%8.13M | 213.39%5.25M | 15.74%1.89M | 27.05%1.37M | 223.48%37.64M | -84.13%1.67M | -84.41%1.63M | -87.63%1.07M | -51.15%11.63M | -33.55%10.55M |
| -Including: Investment income associates | ---- | ---- | ---- | ---- | 11,937.19%35.02M | ---- | ---- | ---- | -203.53%-295.85K | 120.18%59.66K |
| Asset deal income | -693.83%-620.82K | -97.08%1.19K | -98.13%1.42K | ---- | 294.54%104.54K | -55.79%40.6K | -14.34%75.81K | -19.43%3.85K | -99.96%26.5K | -99.85%91.83K |
| Other revenue | 7.39%13.99M | 102.83%12.32M | 101.63%9.89M | 258.42%3.93M | 123.47%13.03M | 36.45%6.07M | 115.35%4.91M | 1.25%1.1M | 19.15%5.83M | 34.19%4.45M |
| Operating profit | 11.05%566.24M | 23.92%430.61M | 28.71%277.16M | 46.77%144.93M | 67.87%509.92M | 64.64%347.49M | 57.75%215.33M | 40.53%98.75M | -21.13%303.75M | -33.47%211.06M |
| Add:Non operating Income | 48.46%176.78K | -91.40%39.69K | -97.54%11.25K | -32.51%10.23K | 546.30%119.07K | 3,866.86%461.66K | 7,608.48%456.68K | 269.04%15.16K | -59.65%18.42K | -89.21%11.64K |
| Less:Non operating expense | 338.10%2.21M | 400.32%2.04M | 556.22%1.97M | -90.71%24.86K | 64.80%504.16K | 47.48%407.52K | 95.29%299.71K | 189.27%267.54K | -83.55%305.92K | -64.00%276.33K |
| Total profit | 10.73%564.21M | 23.32%428.61M | 27.71%275.21M | 47.13%144.92M | 67.91%509.53M | 64.87%347.54M | 58.04%215.49M | 40.35%98.5M | -20.83%303.46M | -33.42%210.79M |
| Less:Income tax cost | 34.79%67.55M | 29.67%50.68M | 38.86%30.03M | 40.42%21.46M | 36.84%50.11M | 69.51%39.09M | 5.86%21.62M | 42.91%15.28M | -34.52%36.62M | -55.95%23.06M |
| Net profit | 8.11%496.66M | 22.52%377.93M | 26.47%245.18M | 48.36%123.46M | 72.17%459.42M | 64.30%308.46M | 67.23%193.87M | 39.89%83.22M | -18.49%266.84M | -28.95%187.74M |
| Net profit from continuing operation | 8.11%496.66M | 22.52%377.93M | 26.47%245.18M | 48.36%123.46M | 72.17%459.42M | 64.30%308.46M | 67.23%193.87M | 39.89%83.22M | -18.49%266.84M | -28.95%187.74M |
| Less:Minority Profit | 19.11%47.43M | 27.96%39.67M | 28.49%25.17M | 101.85%14.15M | 96.46%39.82M | 93.46%31M | 96.02%19.59M | 61.68%7.01M | 71.52%20.27M | 59.31%16.02M |
| Net profit of parent company owners | 7.06%449.23M | 21.91%338.26M | 26.24%220.01M | 43.44%109.31M | 70.17%419.6M | 61.58%277.46M | 64.51%174.28M | 38.18%76.21M | -21.86%246.57M | -32.45%171.71M |
| Earning per share | ||||||||||
| Basic earning per share | 8.51%0.51 | 22.11%0.3811 | 25.00%0.25 | 43.41%0.1229 | 67.86%0.47 | 61.63%0.3121 | 66.67%0.2 | 38.23%0.0857 | -20.00%0.28 | -32.46%0.1931 |
| Diluted earning per share | 8.51%0.51 | 22.11%0.3811 | 25.00%0.25 | 43.41%0.1229 | 67.86%0.47 | 61.63%0.3121 | 66.67%0.2 | 38.23%0.0857 | -20.00%0.28 | -32.46%0.1931 |
| Other composite income | -49.87%2.37M | -162.35%-5.66M | -101.67%-200.5K | 77.92%-873.34K | -78.56%4.73M | -66.05%9.07M | 1.43%11.98M | -158.64%-3.95M | 415.62%22.07M | 1,230.50%26.72M |
| Other composite income of parent company owners | -31.41%3M | -160.20%-5.21M | -98.51%170.02K | 85.24%-569.24K | -79.78%4.37M | -66.81%8.66M | -0.13%11.39M | -143.41%-3.86M | 416.71%21.59M | 1,231.48%26.1M |
| Other composite income of minority owners | -269.82%-622.2K | -207.94%-441.42K | -163.22%-370.52K | -213.02%-304.11K | -23.85%366.38K | -33.99%408.94K | 45.83%586.04K | -274.28%-97.15K | 373.26%481.12K | 1,190.98%619.49K |
| Total composite income | 7.52%499.03M | 17.24%372.27M | 19.01%244.98M | 54.66%122.59M | 60.65%464.15M | 48.06%317.53M | 61.15%205.85M | 36.76%79.26M | -9.82%288.91M | -18.11%214.45M |
| Total composite income of parent company owners | 6.67%452.23M | 16.40%333.05M | 18.59%220.18M | 50.30%108.74M | 58.10%423.97M | 44.64%286.12M | 58.23%185.67M | 35.07%72.35M | -13.14%268.17M | -21.47%197.81M |
| Total composite income of minority owners | 16.48%46.8M | 24.89%39.22M | 22.92%24.8M | 100.28%13.85M | 93.67%40.18M | 88.72%31.41M | 94.08%20.18M | 57.42%6.91M | 78.25%20.75M | 66.41%16.64M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.